A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Friday, 19 April 2013

GlaxoSmithKline reference: UK consultation

Readers of the IPKat weblog will already have seen the news that the United Kingdom's Intellectual Property Office has improved the mechanics of its procedures for consulting interested parties over intellectual property references to the Court of Justice of the European Union.

The first "new" consultation, which helpfully gives interested parties some background information concerning the questions referred and also gives them more time in which to respond, is in relation to an SPC case, GlaxoSmithKline v Comptroller General of Patents, noted here on The SPC Blog.

No comments: